BBTV

About Us

Allogeneic or Autologous? – Stem Cell Review (EP2)

« ISIS – Isis Pharma CEO Stanley Crooke Interviewed by Mark Monane
Biological Processes & Industrial Production – Stem Cell Review (EP3) »
  • Chapters
  • 1. Technology & Business Models
  • 2. Intellectual Property
  • 3. Regulatory Concerns
  • 4. Transplantation & Immune Rejection

1. Technology & Business Models


2. Intellectual Property


3. Regulatory Concerns


4. Transplantation & Immune Rejection


Reviewing the technology, business models, intellectual property, regulatory concerns, transplantation and immune rejection.

This is the Episode 2 of the Stem Cell Review, aired on October 8st, 2009

Related Videos:

  1. Stem Cells at a Glance – Stem Cell Review (EP1)
  2. Tools for Drug Screening – Stem Cell Review (EP4)
  3. Stem Cells & Diabetes – Stem Cell Review (EP8)
  4. Biological Processes & Industrial Production – Stem Cell Review (EP3)
  5. Tissue Repair – Stem Cell Review (EP10)
  6. Mesenchymal Stem Cells and Connective Disorders – Stem Cell Review (EP6)
  7. I-Stem, Peschanski’s Stem Cell Technology Platform
  8. Autoimmune Diseases & Blood Disorders – Stem Cell Review (EP9)
  9. Neural Stem Cells and CNS Disorder – Stem Cell Review (EP7)
  10. Looking Forward to 2015 – Stem Cell Review (EP5)
« ISIS – Isis Pharma CEO Stanley Crooke Interviewed by Mark Monane
Biological Processes & Industrial Production – Stem Cell Review (EP3) »

Post a Comment

Click here to cancel reply.

Your email is never published nor shared. Required fields are marked *

*
*
  • About the Series


    The Stem Cell Review is a 10-part original series on the science, medical applications, and business of stem cells.


    This program will give you a clear and concise understanding of the state of stem cells today, with the additional depth and expertise you would come to expect from the most renown authorities in the field.


    The Stem Cell Review is a BioBusiness.TV Original Program, presented by Bill Kridel, produced by Jean-Loup Romet-Lemonne and Jonathan Teper.

  • Related Videos

    1. Stem Cells at a Glance – Stem Cell Review (EP1)
    2. Tools for Drug Screening – Stem Cell Review (EP4)
    3. Stem Cells & Diabetes – Stem Cell Review (EP8)
    4. Biological Processes & Industrial Production – Stem Cell Review (EP3)
    5. Tissue Repair – Stem Cell Review (EP10)
    6. Mesenchymal Stem Cells and Connective Disorders – Stem Cell Review (EP6)
    7. I-Stem, Peschanski’s Stem Cell Technology Platform
    8. Autoimmune Diseases & Blood Disorders – Stem Cell Review (EP9)
    9. Neural Stem Cells and CNS Disorder – Stem Cell Review (EP7)
    10. Looking Forward to 2015 – Stem Cell Review (EP5)
  • ABOUT BIOBUSINESS.TV
  • BioBusiness.TV is the first independent Internet TV Network for biotechnology professionals. We create and syndicate video-based industry focused shows and series that range from scientific breakthroughs, to equity analyst insights, as well as C-level executive and investor interviews on strategy, management, policy, marketing, science and more. We strive to enhance the quality and accessibility of industry video programming, and to deliver information biotechnology professionals can rely on to make sound and informed decisions.

  • PARTNERING WITH BIOBUSINESS.TV
  • If you’ve got great video programs and a growing audience, let BioBusiness.TV help you take it to the next level through our Partner Program. You can reach out to us through our ‘contact us’ page.

  • DISCLAIMER
  • Viewers should verify all claims and do their own due diligence before investing in any securities mentioned on BioBusiness.TV.

  • COPYRIGHT © 2011 BIO BUSINESS TV, INC. All Rights Reserved